Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
Alison Birtle(Lancashire Teaching Hospitals NHS Foundation Trust), Mark Johnson(Newcastle upon Tyne Hospitals NHS Foundation Trust), John Chester(Cardiff University), Robert J. Jones(University of Glasgow), David Dolling(Institute of Cancer Research), Richard T. Bryan(University of Birmingham), Christopher Harris, Andrew Winterbottom, Anthony Blacker(University Hospitals Coventry and Warwickshire NHS Trust), James W.F. Catto(University of Sheffield), Prabir Chakraborti, Jenny Donovan(University of Bristol), Paul Anthony Elliott(The Christie NHS Foundation Trust), Ann French(Southend University Hospital NHS Foundation Trust), Satinder Jagdev(Leeds Teaching Hospitals NHS Trust), Benjamin Jenkins(Institute of Cancer Research), Francis X. Keeley(North Bristol NHS Trust), Roger Kockelbergh(University Hospitals of Leicester NHS Trust), Thomas Powles(Barts Health NHS Trust), John Wagstaff(Singleton Hospital), Caroline Wilson(University of Bristol), Rachel Todd(Institute of Cancer Research), Rebecca Lewis(Institute of Cancer Research), Emma Hall(Institute of Cancer Research)
Cited by 524Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis